A double-blind multicenter, randomized, placebo-controlled single dose study to evaluate the safety and efficacy of Trexima in the acute treatment of migraine headaches.
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2010
At a glance
- Drugs Naproxen sodium; Naproxen sodium/sumatriptan; Sumatriptan
- Indications Migraine
- Focus Registrational; Therapeutic Use
- Sponsors POZEN
- 13 Sep 2009 Results from a pooled analysis (CTP profiles 700021536 and 700021530) were reported at the 14th International Headache Congress & the 51st Annual Scientific Meeting of the American Headache Society (Joint meeting).
- 10 Mar 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History